Our Products & Technologies

We have used our cell expansion and screening technologies to develop “off-the-shelf” stem cell therapies for serious conditions such as retinitis pigmentosa and ischaemic stroke where significant populations of patients exist, yet no alternative pharmacological treatments are currently available.